Phase II clinical study in patients with Parkinson's disease not taking L-DOPA
A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkinson's disease not taking L-DOPA A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkin ...
Phase II clinical study in patients with Parkinson's disease taking L-DOPA
A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkinson's disease taking L-DOPA A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkin ...